about
Intranasal M cell uptake of nanoparticles is independently influenced by targeting ligands and buffer ionic strength.In vitro selection of a peptide antagonist of growth hormone secretagogue receptor using cDNA display.Mucoadhesive nanomedicines: characterization and modulation of mucoadhesion at the nanoscale.Recent trends in oral transmucosal drug delivery systems: an emphasis on the soft palatal route.Mucoadhesive therapeutic compositions: a patent review (2011-2014).Development of a buccal mucoadhesive film for fast dissolution: mathematical rationale, production and physicochemical characterization.A pilot study on a new anchoring mechanism for surgical applications based on mucoadhesives
P2860
Q34025399-5CEF3432-9679-42A9-80EA-834F45B772B6Q34313652-95B4411C-AD68-42ED-A3FD-3608B7B3DDF5Q37877717-3012D982-D91F-4603-8394-59D9495E9837Q38003426-56C0B515-02B6-46FA-AF66-F8C7592C37C0Q38706683-5A1829B5-6A44-45D9-AB9B-454742FFE949Q45375065-71D03EB1-7BF1-4FB1-BE95-B160A687F4CEQ56837174-BD17BC2E-0D97-4708-910A-73F60FA2CAA0
P2860
description
article
@en
наукова стаття, опублікована у квітні 2009
@uk
name
Mucoadhesive drug delivery systems (Review)
@en
type
label
Mucoadhesive drug delivery systems (Review)
@en
prefLabel
Mucoadhesive drug delivery systems (Review)
@en
P2093
P1476
Mucoadhesive drug delivery systems (Review)
@en
P2093
E. A. Kharenko
N. B. Demina
N. I. Larionova
P2860
P304
P356
10.1007/S11094-009-0271-6
P577
2009-04-01T00:00:00Z